Archives: Agenda

• Identifying how clinical strategy and data quality impact investment decisions
• Translating investor expectations into practical changes in trial design and execution
• Applying these insights to improve funding strategy in a tougher market

Understanding when China makes sense, when it doesn’t, and how to build a practical operational pathway

• Evaluating when China is the right fit for global development strategies
• Weighing the benefits, risks and timelines of China-linked studies
• Exploring Australia and other ICH-aligned pathways into the US market
• Comparing China, Australia and Central & Eastern Europe for trial execution
• Aligning clinical operations, CMC, manufacturing and quality strategies
• Sharing practical lessons from sponsors currently assessing China expansion

2 x Biopharma panel seats available

1 x Vendor panel seat available

• Understanding how clinical trials continue during war and infrastructure disruption
• Managing patient safety supply chain and data integrity under extreme conditions
• Applying lessons from Ukraine to improve resilience and contingency planning